Table 4.
Best overall response and induction regime
| Patient no. | Status at enrollment | Best overall response | Induction regimen | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Bor | Len | Dex | Dox | Mel | CY | RT | HSCT | |||
| 1 | sCR | sCR | ✓ | ✓ | ✓ | ✓ | ||||
| 2 | sCR | sCR | ✓ | ✓ | ✓ | ✓ | ||||
| 3 | sCR | sCR | ✓ | ✓ | ||||||
| 4 | sCR | sCR | ✓ | ✓ | ✓ | ✓ | ||||
| 5 | CR | sCR | ✓ | ✓ | ||||||
| 6 | VGPR | sCR | ✓ | ○ | ✓ | ✓ | ||||
| 7 | VGPR | sCR | ✓ | ✓ | ✓ | |||||
| 8 | PR | VGPR | ✓ | ✓ | ✓ | |||||
| 9 | PR | PR | ✓ | ✓ | ✓ | ✓ | ||||
| 10 | PR | PR | ✓ | ✓ | ||||||
| 11 | PR | PR | ✓ | ✓ | ✓ | ✓ | ✓ | |||
| 12 | PR | PR | ✓ | ✓ | ||||||
| 13 | PR | PR | ✓ | ✓ | ✓ | ✓ | ✓ | |||
| 14 | PR | PR | ✓ | ✓ | ✓ | ✓ | ||||
| 15 | PR | PR | ✓ | ✓ | ✓ | |||||
| 16 | PR | PR | ✓ | ✓ | ✓ | ✓ | ||||
| Total (n = 16) | 16 | 16 | 13 | 7 | 14 | 4 | 3 | 2 | 7 | 4 |
Bor bortezomib, Len lenalidomide, Dex dexamethasone, Dox doxorubicin, Mel melphalan, CY cyclophosphamide, RT radiation, HSCT hematopoietic stem cell transplantation